PurePRP is a proprietary form of autologous platelet-rich plasma developed by EmCyte Corporation. It contains a complex composition of cellular components derived from your blood biologic that can be used to treat and repair a host of injuries and conditions.
It is the cornerstone of the consortium of regenerative therapies used in modern medicine and rapidly becoming a standard of care. It’s chosen over surgery for many conditions, ranging from degenerative joint disease to tendon and ligament injuries because its regenerative power is shown to play an adjunctive role in clinical outcomes. You can find more about pure PRP in NJ via https://5linebiologics.com/platelet-rich-plasma/.
It is unique in that it is the only point of care system that selectively removes wound inhibiting factors while concentrating regenerative cellular components. Deliverable platelets are the actual volume of viable platelets contained in platelet-rich plasma (PRP) treatment samples.
Pure PRP provides between 7 and 21 billion platelets in a 7mL treatment sample, however, the typical deliverables for patients with normal platelet counts are around 9 billion platelets. This is up to 2 billion higher than the minimum required treatment amount.
High volumes of deliverable platelets enhance the volumetric activity of platelet growth factors and cytokines. Platelet alpha granules contain various platelet growth factors that can promote tissue repair along with platelet cytokines that can provide the chemical stimulus needed to attract and direct regenerative cells to injured tissue. Deliverable platelet count is the most important measure of the power of the PRP biologic.